190 related articles for article (PubMed ID: 16607696)
41. Phytoestrogens as cardioprotective agents.
Park D; Huang T; Frishman WH
Cardiol Rev; 2005; 13(1):13-7. PubMed ID: 15596022
[TBL] [Abstract][Full Text] [Related]
42. [The effects of phytoestrogen therapy on the endometrium in postmenopausal women].
Caserta L; Caserta R; Torella M; Nappo C; De Lucia D; Panariello S
Minerva Ginecol; 2005 Oct; 57(5):551-5. PubMed ID: 16205600
[TBL] [Abstract][Full Text] [Related]
43. Daidzein-rich isoflavone-aglycones for menopausal symptoms.
Ricciotti HA; Khaodhiar L; Blackburn GL
Int J Gynaecol Obstet; 2005 Apr; 89(1):65-6. PubMed ID: 15777908
[No Abstract] [Full Text] [Related]
44. Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries.
Penotti M; Fabio E; Modena AB; Rinaldi M; Omodei U; Viganó P
Fertil Steril; 2003 May; 79(5):1112-7. PubMed ID: 12738504
[TBL] [Abstract][Full Text] [Related]
45. First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055.
Raus K; Brucker C; Gorkow C; Wuttke W
Menopause; 2006; 13(4):678-91. PubMed ID: 16837890
[TBL] [Abstract][Full Text] [Related]
46. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
Endrikat J; Graeser T; Mellinger U; Ertan K; Holz C
Maturitas; 2007 Oct; 58(2):201-7. PubMed ID: 17889463
[TBL] [Abstract][Full Text] [Related]
47. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women.
Joffe H; Hall JE; Gruber S; Sarmiento IA; Cohen LS; Yurgelun-Todd D; Martin KA
Menopause; 2006; 13(3):411-22. PubMed ID: 16735938
[TBL] [Abstract][Full Text] [Related]
48. Hot flashes--a review of the literature on alternative and complementary treatment approaches.
Philp HA
Altern Med Rev; 2003 Aug; 8(3):284-302. PubMed ID: 12946239
[TBL] [Abstract][Full Text] [Related]
49. Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women.
Manonai J; Chittacharoen A; Udomsubpayakul U; Theppisai H; Theppisai U
Menopause; 2008; 15(3):530-5. PubMed ID: 18202589
[TBL] [Abstract][Full Text] [Related]
50. The menopausal hot flush--anything new?
Sturdee DW
Maturitas; 2008 May; 60(1):42-9. PubMed ID: 18384981
[TBL] [Abstract][Full Text] [Related]
51. A double-blind placebo-controlled study to evaluate the effect of progestelle progesterone cream on postmenopausal women.
Benster B; Carey A; Wadsworth F; Vashisht A; Domoney C; Studd J
Menopause Int; 2009 Jun; 15(2):63-9. PubMed ID: 19465671
[TBL] [Abstract][Full Text] [Related]
52. [PHYTOESTROGENS: MECHANISMS OF CORRECTION OF CARDIOVASCULAR COMPLICATIONS OF CLIMACTERIC SYNDROME.].
Plotnikoval TM; Anishchenko AM; Plotnikov MB
Eksp Klin Farmakol; 2017; 80(1):39-44. PubMed ID: 29874002
[TBL] [Abstract][Full Text] [Related]
53. Nonhormonal management of postmenopausal women: effects of a red clover based isoflavones supplementation on climacteric syndrome and cardiovascular risk serum profile.
Mainini G; Torella M; Di Donna MC; Esposito E; Ercolano S; Correa R; Cucinella G; Stradella L; Luisi A; Basso A; Cerreto FV; Cicatiello R; Matteo M; De Franciscis P
Clin Exp Obstet Gynecol; 2013; 40(3):337-41. PubMed ID: 24283160
[TBL] [Abstract][Full Text] [Related]
54. Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy.
Wang Y; Hernandez G; Mack WJ; Schneider LS; Yin F; Brinton RD
Menopause; 2020 Jan; 27(1):57-65. PubMed ID: 31567873
[TBL] [Abstract][Full Text] [Related]
55. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
[TBL] [Abstract][Full Text] [Related]
56. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.
Messina M; McCaskill-Stevens W; Lampe JW
J Natl Cancer Inst; 2006 Sep; 98(18):1275-84. PubMed ID: 16985246
[TBL] [Abstract][Full Text] [Related]
57. [Efficacy of standardized isoflavones extract (Soyfem) (52-104 mg/24h) in moderate and medium-severe climacteric syndrome].
Drews K; Seremak-Mrozikiewicz A; Puk E; Kaluba-Skotarczak A; Malec M; Kazikowska A
Ginekol Pol; 2007 Apr; 78(4):307-11. PubMed ID: 17621994
[TBL] [Abstract][Full Text] [Related]
58. Red clover isoflavones in practice: a clinician's view.
Pitkin J
J Br Menopause Soc; 2004 Mar; 10 Suppl 1():7-12. PubMed ID: 15107200
[TBL] [Abstract][Full Text] [Related]
59. Synergic effect of phytoestrogens and exercise training on cardiovascular risk profile in exercise-responder postmenopausal women: a pilot study.
Riesco E; Aubertin-Leheudre M; Maltais ML; Audet M; Dionne IJ
Menopause; 2010; 17(5):1035-9. PubMed ID: 20539245
[TBL] [Abstract][Full Text] [Related]
60. Dietary phytoestrogen intake--lignans and isoflavones--and breast cancer risk (Canada).
Cotterchio M; Boucher BA; Kreiger N; Mills CA; Thompson LU
Cancer Causes Control; 2008 Apr; 19(3):259-72. PubMed ID: 17992574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
